1.
|
Phase: Phase IV
Type: Screening
Status: Active
Age: 40 to 65
Sponsor: Other
Protocol IDs: CEC_cribado_CCR, NCT01557101
|
|
2.
|
Phase: Phase IV
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 11042705, NCT01695863
|
|
3.
|
Phase: Phase III, Phase II
Type: Screening
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 190-CLD-AOS, NCT00867724
|
|
4.
|
Phase: Phase III
Type: Behavioral study, Health services research, Screening
Status: Active
Age: 50 to 74
Sponsor: NCI
Protocol IDs: TJUH-2006-44, 2006-44, NCT00617071
|
|
5.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 50 to 79
Sponsor: NCI
Protocol IDs: TJUH-RSGT-08-017-01-CPPB, RSGT-08-017-01-CPPB, 08G.89, NCT00893295
|
|
6.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 55 to 64
Sponsor: Other
Protocol IDs: NordICC, NCT00883792
|
|
7.
|
Phase: Phase III
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000654114, FFCD-PRODIGE-13, 2009-A00536-51, EU-20979, PRODIGE 13, FFCD 0902, NCT00995202
|
|
8.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 40 to 75
Sponsor: Other
Protocol IDs: COLONFAM, NCT01075633
|
|
9.
|
Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRE-2011.125-T, NCT01434199
|
|
10.
|
Phase: Phase III
Type: Screening
Status: Active
Age: 50 to 74
Sponsor: Other
Protocol IDs: 10-163, NCT01506687
|
|
11.
|
Phase: Phase III
Type: Screening
Status: Approved-not yet active
Age: 50 to 74
Sponsor: Other
Protocol IDs: C RCpilotNorway, NCT01538550
|
|
12.
|
Phase: Phase II, Phase I
Type: Diagnostic, Screening, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSP-IL-LIT-0703_S_01, NCT00715325
|
|
13.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 50 to 80
Sponsor: NCI
Protocol IDs: NCCTG-GLNE010, GLNE 010, GLNE010, NCT01511653
|
|
14.
|
Phase: Phase I
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: 633, NCT00124163
|
|
15.
|
Phase: Phase I
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 9461701245, NCT00302679
|
|
16.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 9461700610, NCT00173277
|
|
17.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 HS013912-03, NCT00251862
|
|
18.
|
Phase: No phase specified
Type: Behavioral study, Health services research, Screening
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: FCCC-05016, 05-016, FCCC-IRB-05-016, NCT00459030
|
|
19.
|
Phase: No phase specified
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 070504, NCT00534053
|
|
20.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Screening, Tissue collection/Repository
Status: Active
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000583154, VU-VICC-GI-0294, VU-VICC-020603, VU-VICC-020531, VICC-GI-0294, NCT00625066
|
|
21.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AR0002, 00371, NCT00613262
|
|
22.
|
Phase: No phase specified
Type: Screening, Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 200802031R, NCT00745927
|
|
23.
|
Phase: No phase specified
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 50 to 79
Sponsor: NCI
Protocol IDs: CCUM-HUM00016999, HUM00016999, 4888, H8000-32900-01, NCT00955188
|
|
24.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: HIC0809004192, NCT00859625
|
|
25.
|
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ASC-FIT, NCT00892593
|
Mobile | Español
